Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27171027 | 0.91 | PTGS2 (0.32) | PTGS2PTGS1 | |
| SCHEMBL16829412 | 0.87 | PTGS2 (0.35) | PTGS2PTGS1TNFRSF1ACYP3A4EGFR | |
| SCHEMBL16829408 | 0.84 | PTGS2 (0.36) | PTGS2PTGS1TNFRSF1ACYP3A4 | |
| SCHEMBL16829568 | 0.80 | PTGS2 (0.36) | PTGS2PTGS1TNFRSF1ACYP3A4ALDH1A1 | |
| SCHEMBL28724498 | 0.79 | ALOX5AP (0.32) | PTGS2 | |
| SCHEMBL6031753 | 0.79 | RXRB (0.36) | ALDH1A1 | |
| SCHEMBL29594786 | 0.79 | RXRB (0.36) | ALDH1A1 | |
| SCHEMBL16829504 | 0.78 | PTGS2 (0.37) | PTGS2PTGS1TNFRSF1ACYP3A4EGFR | |
| SCHEMBL6150740 | 0.77 | RXRB (0.35) | — | |
| SCHEMBL18280777 | 0.76 | PTGS2 (0.37) | PTGS2PTGS1TNFRSF1ACYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12195563-B2 | Polyolefin-based ionomers and production thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240084056-A1 | Polyolefin-Based Ionomers and Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-03-14 | — | — | US | disclosed |
| EP-4271718-A1 | POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-11-08 | — | — | EP | disclosed |
| US-11492425-B2 | Metallocene catalyst compositions and polymerization process therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-11-08 | — | — | US | disclosed |
| US-20220213241-A1 | Polyolefin-Based Ionomers and Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2022-07-07 | — | — | US | disclosed |
| WO-2022146634-A1 | POLYOLEFIN-BASED IONOMERS AND PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-07-07 | — | — | WO | disclosed |
| US-11001657-B2 | Unbridged indacenyl metallocenes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-05-11 | — | — | US | disclosed |
| US-11001657-B2 | Unbridged indacenyl metallocenes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2021-05-11 | — | — | US | disclosed |
| US-10723821-B2 | Supported metallocene catalyst systems for polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-28 | — | — | US | disclosed |
| CN-111225927-A | Unbridged indacenyl metallocenes | 埃克森美孚化学专利公司 | 2020-06-02 | — | — | CN | disclosed |
| US-20190119418-A1 | Unbridged Indacenyl Metallocenes | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-25 | — | — | US | disclosed |
| US-20190119418-A1 | Unbridged Indacenyl Metallocenes | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-25 | — | — | US | disclosed |
| CN-109312013-A | Metallocene catalyst compositions and the polymerization for using it | 埃克森美孚化学专利公司 | 2019-02-05 | — | — | CN | disclosed |
| US-20180162964-A1 | Supported Metallocene Catalyst Systems for Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10723821-B2 | Supported metallocene catalyst systems for polymerization | LATS1, PCNA, RAD52 | PTGS2 636/4885PTGS1 1006/4885TNFRSF1A 1711/4885 |
| US-11001657-B2 | Unbridged indacenyl metallocenes | MT-ND4L, MT-ND4, ACSL4 | PTGS2 1259/4885PTGS1 1676/4885TNFRSF1A 2257/4885 |
| US-11492425-B2 | Metallocene catalyst compositions and polymerization process therewith | TERT, MDM4, PCBP1 | PTGS2 2131/4885PTGS1 3180/4885TNFRSF1A 3509/4885 |
| US-20180162964-A1 | Supported Metallocene Catalyst Systems for Polymerization | LATS1, PCNA, RAD52 | PTGS2 636/4885PTGS1 1006/4885TNFRSF1A 1711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.